📣 VC round data is live. Check it out!

Median Technologies Valuation Multiples

Discover revenue and EBITDA valuation multiples for Median Technologies and similar public comparables like Stratec, Affluent Medical, Orchestra BioMed, Asterasys and more.

Median Technologies Overview

About Median Technologies

Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.


Founded

2002

HQ

France

Employees

164

Financials (LTM)

Revenue: $29M
EBITDA: ($18M)

EV

$243M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Median Technologies Financials

Median Technologies reported last 12-month revenue of $29M and negative EBITDA of ($18M).

In the same LTM period, Median Technologies generated ($18M) in EBITDA losses and had net loss of ($31M).

Revenue (LTM)


Median Technologies P&L

In the most recent fiscal year, Median Technologies reported revenue of $27M and EBITDA of ($19M).

Median Technologies is unprofitable as of last fiscal year, with gross margin of 102%, EBITDA margin of (68%), and net margin of (145%).

See analyst estimates for Median Technologies
LTMLast FY202320242025202620272028
Revenue$29M$27M$26M$27M$27M
Gross Profit$28M$27M$28M$28M
Gross Margin102%104%104%103%
EBITDA($18M)($19M)($23M)($22M)($29M)
EBITDA Margin(64%)(68%)(89%)(84%)(108%)
EBIT Margin(69%)(68%)(103%)(97%)(68%)
Net Profit($31M)($40M)($27M)($29M)($40M)
Net Margin(109%)(145%)(103%)(110%)(146%)
Net Debt$2M

Financial data powered by Morningstar, Inc.

Median Technologies Stock Performance

Median Technologies has current market cap of $239M, and enterprise value of $243M.

Market Cap Evolution


Median Technologies' stock price is $6.26.

Median Technologies share price increased by 10.9% in the last 30 days, and by 146.7% in the last year.

Median Technologies has an EPS (earnings per share) of $-1.04.

See more trading valuation data for Median Technologies
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$243M$239M-2.0%10.9%9.3%146.7%$-1.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Median Technologies Valuation Multiples

Median Technologies trades at 8.5x EV/Revenue multiple, and (13.2x) EV/EBITDA.

See NTM and 2027E valuation multiples for Median Technologies

EV / Revenue (LTM)


Median Technologies Financial Valuation Multiples

As of May 23, 2026, Median Technologies has market cap of $239M and EV of $243M.

Median Technologies has a P/E ratio of (7.7x).

LTMLast FY202320242025202620272028
EV/Revenue8.5x8.9x9.4x9.1x8.9x
EV/EBITDA(13.2x)(13.1x)(10.5x)(10.8x)(8.3x)
EV/EBIT(12.3x)(13.1x)(9.1x)(9.3x)(13.1x)
EV/Gross Profit8.7x9.0x8.8x8.7x
P/E(7.7x)(6.0x)(8.9x)(8.1x)(6.0x)
EV/FCF(12.5x)(11.7x)(9.7x)(11.0x)(11.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Median Technologies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Median Technologies Margins & Growth Rates

Median Technologies grew revenue by 13% but EBITDA decreased by 2% in the last fiscal year.

In the most recent fiscal year, Median Technologies reported gross margin of 102%, EBITDA margin of (68%), and net margin of (145%).

See estimated margins and future growth rates for Median Technologies

Median Technologies Margins

Last FY202420252026202720282029
Gross Margin102%104%103%
EBITDA Margin(68%)(84%)(108%)(59%)
EBIT Margin(68%)(97%)(68%)(67%)
Net Margin(145%)(110%)(146%)(57%)
FCF Margin(76%)(83%)(78%)(56%)

Median Technologies Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth13%3%2%13%
Gross Profit Growth3%1%
EBITDA Growth(2%)(3%)30%(38%)
EBIT Growth11%(2%)(29%)11%
Net Profit Growth(55%)10%35%(55%)
FCF Growth(17%)(12%)(5%)(18%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Median Technologies Operational KPIs

Median Technologies' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.

Median Technologies' Rule of 40 is (46%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Median Technologies' Rule of X is (26%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Median Technologies
LTMLast FY202320242025202620272028
Rule of 40(43%)(46%)
Bessemer Rule of X(11%)(26%)
Revenue per Employee$0.2M
Opex per Employee$0.3M
S&M Expenses to Revenue1%2%4%1%
G&A Expenses to Revenue2%1%2%2%
Opex to Revenue170%207%201%171%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Median Technologies Competitors

Median Technologies competitors include Stratec, Affluent Medical, Orchestra BioMed, Asterasys, Humacyte, OraSure, Onward Medical, Quantum-Si, Ascom and Profound Medical.

Most Median Technologies public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Stratec1.2x1.2x9.3x8.9x
Affluent Medical207.8x(11.6x)
Orchestra BioMed4.9x8.0x(3.2x)(2.4x)
Asterasys9.0x7.7x27.2x22.3x
Humacyte121.8x60.2x(11.2x)
OraSure0.7x0.7x(2.0x)(2.1x)
Onward Medical28.3x17.2x(3.8x)(3.2x)
Quantum-Si43.1x55.7x(1.3x)(1.2x)

This data is available for Pro users. Sign up to see all Median Technologies competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Median Technologies

When was Median Technologies founded?Median Technologies was founded in 2002.
Where is Median Technologies headquartered?Median Technologies is headquartered in France.
How many employees does Median Technologies have?As of today, Median Technologies has over 164 employees.
Is Median Technologies publicly listed?Yes, Median Technologies is a public company listed on Euronext Paris.
What is the stock symbol of Median Technologies?Median Technologies trades under ALMDT ticker.
When did Median Technologies go public?Median Technologies went public in 2011.
Who are competitors of Median Technologies?Median Technologies main competitors include Stratec, Affluent Medical, Orchestra BioMed, Asterasys, Humacyte, OraSure, Onward Medical, Quantum-Si, Ascom, Profound Medical.
What is the current market cap of Median Technologies?Median Technologies' current market cap is $239M.
What is the current revenue of Median Technologies?Median Technologies' last 12 months revenue is $29M.
What is the current revenue growth of Median Technologies?Median Technologies revenue growth (NTM/LTM) is 21%.
What is the current EV/Revenue multiple of Median Technologies?Current revenue multiple of Median Technologies is 8.5x.
Is Median Technologies profitable?No, Median Technologies is not profitable.
What is the current EBITDA of Median Technologies?Median Technologies has negative EBITDA and is not profitable.
What is Median Technologies' EBITDA margin?Median Technologies' last 12 months EBITDA margin is (64%).
What is the current EV/EBITDA multiple of Median Technologies?Current EBITDA multiple of Median Technologies is (13.2x).
What is the current FCF of Median Technologies?Median Technologies' last 12 months FCF is ($19M).
What is Median Technologies' FCF margin?Median Technologies' last 12 months FCF margin is (68%).
What is the current EV/FCF multiple of Median Technologies?Current FCF multiple of Median Technologies is (12.5x).
How many companies Median Technologies has acquired to date?Median Technologies hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Median Technologies has invested to date?Median Technologies hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Median Technologies

Lists including Median Technologies

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial